EMERALD ADVISERS, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 72 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$2,646,000
+54.5%
642,226
-4.0%
0.11%
+45.3%
Q2 2020$1,713,000
-6.1%
669,042
+6.0%
0.08%
-29.2%
Q1 2020$1,825,000
-23.4%
631,447
+0.4%
0.11%
+5.0%
Q4 2019$2,384,000
-27.1%
629,124
-1.6%
0.10%
-34.0%
Q3 2019$3,269,000
-24.7%
639,094
-8.7%
0.15%
-12.1%
Q2 2019$4,341,000
-2.5%
700,176
+11.8%
0.17%
-3.9%
Q1 2019$4,453,000
-19.8%
626,247
-3.7%
0.18%
-33.7%
Q4 2018$5,554,000
-58.1%
650,349
-1.8%
0.27%
-43.9%
Q3 2018$13,264,000
-19.8%
662,544
+3.5%
0.49%
-22.0%
Q2 2018$16,529,000
+10.5%
639,934
+2.2%
0.62%
+4.0%
Q1 2018$14,964,000
-18.7%
626,113
+15.3%
0.60%
-15.4%
Q4 2017$18,399,000
+64.6%
542,897
+2.8%
0.71%
+55.8%
Q3 2017$11,179,000
+20.0%
528,067
-0.9%
0.46%
+17.0%
Q2 2017$9,317,000
+2.6%
532,727
+2.7%
0.39%
+4.3%
Q1 2017$9,077,000
+3.6%
518,685
+0.0%
0.37%
-0.3%
Q4 2016$8,763,000
+5.9%
518,545
+2.8%
0.37%
+1.6%
Q3 2016$8,278,000
+7.2%
504,474
-1.1%
0.37%
-1.1%
Q2 2016$7,724,000
+4.7%
510,1940.0%0.37%
+3.6%
Q1 2016$7,377,000
-43.6%
510,194
+10.4%
0.36%
-41.9%
Q4 2015$13,085,000
+122.4%
462,051
+31.4%
0.62%
+101.3%
Q3 2015$5,884,000
-35.6%
351,521
+0.8%
0.31%
-29.6%
Q2 2015$9,143,000
+61.8%
348,721
+8.1%
0.44%
+53.5%
Q1 2015$5,652,000
+35.5%
322,631
+34.3%
0.28%
+28.5%
Q4 2014$4,172,000
+39.6%
240,167
+49.7%
0.22%
+24.9%
Q3 2014$2,988,000
+7.8%
160,463
+5.8%
0.18%
+13.5%
Q2 2014$2,772,000151,6190.16%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders